Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Cantor Fitzgerald
Medtronic
Citi
Queensland Health
Fish and Richardson
McKinsey
Farmers Insurance
Accenture
Federal Trade Commission

Generated: February 21, 2018

DrugPatentWatch Database Preview

GERIMAL Drug Profile

« Back to Dashboard

When do Gerimal patents expire, and when can generic versions of Gerimal launch?

Gerimal is a drug marketed by Watson Labs and is included in three NDAs.

The generic ingredient in GERIMAL is ergoloid mesylates. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ergoloid mesylates profile page.
Summary for GERIMAL
Drug patent expirations by year for GERIMAL
Medical Subject Heading (MeSH) Categories for GERIMAL

US Patents and Regulatory Information for GERIMAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs GERIMAL ergoloid mesylates TABLET;ORAL 088207-001 Mar 22, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs GERIMAL ergoloid mesylates TABLET;SUBLINGUAL 086189-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs GERIMAL ergoloid mesylates TABLET;SUBLINGUAL 086188-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Colorcon
Federal Trade Commission
Boehringer Ingelheim
McKesson
US Department of Justice
Covington
US Army
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot